SUMMARYBACKGROUND: Data on spirometrically defined chronic airflow limitation (CAL) are scarce in developing countries.OBJECTIVE: To estimate the prevalence of spirometrically defined CAL in Kashmir, North India.METHODS: Using Burden of Obstructive Lung Disease survey methods, we administered questionnaires to randomly selected adults aged ⩾40 years. Post-bronchodilator spirometry was performed to estimate the prevalence of CAL and its relation to potential risk factors.RESULTS: Of 1100 participants initially recruited, 953 (86.9%) responded and 757 completed acceptable spirometry and questionnaires. The prevalence of a forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio less than the lower limit of normal was 17.3% (4.5) in males and 14.8% (2.1) in females. Risk factors for CAL included higher age, cooking with wood and lower educational status. The prevalence of current smoking was 61% in males and 22% in females; most smoked hookahs. CAL was found equally in non-smoking males and females, and was independently associated with the use of the hookah, family history of respiratory disease and poor education. A self-reported doctor's diagnosis of chronic obstructive pulmonary disease was reported in 8.4/1000 (0.9% of females and 0.8% of males).CONCLUSION:Spirometrically confirmed CAL is highly prevalent in Indian Kashmir, and seems to be related to the high prevalence of smoking, predominantly in the form of hookah smoking.
mechanisms. Although we basically agree, we argue that the underlying mechanism(s) motivating the use of vasopressor(s) must be kept in mind. Increasing BP by a pressor combination increasing the vascular tone via different mechanisms might be correct. This approach will work well if hypotension results mainly from the loss of vascular tone. In this case, the proposed approach fits well with the physiological acute cardiovascular response. Sympathetic stimulation, vasopressin release, and angiotensin level increase interact synergistically to increase the vascular tone. However, the decrease in BP in critically ill patients results from more complex interactive mechanisms (eg, heart failure, hypovolemia, abnormal ventriculo-arterial coupling), for which the pure vascular tone control might be insufficient or dangerous. We do not share the "no sense of a norepinephrine association with epinephrine." Epinephrine is the emergency hormone, which links vascular tone, heart function, and metabolic effects to "escape" the life-threatening situation. Its combination with norepinephrine can be then logical for some patients.The second concept ("catecholamine vasopressor support-sparing strategies") proposes the use of "adjunctive" therapies to reduce pressor support. Although theoretically appealing, such adjunctive therapies are not easy to use in practice.The last concept ("microcirculatory protection") is the oldest but the most recently investigated in critical care. Until now, it seemed obvious that the microcirculation changes might be corrected by therapeutic actions focused on macrocirculation, suggesting that microcirculation is passively impaired. This is very different when microcirculation is impaired by a combination of abnormal systemic circulation associated with pure inflammatory mechanisms at the microcirculation level (activated adhering white cells with microthrombosis). This situation frequently occurs in critically ill patients and could be improved by a combination of cardiovascular hemodynamic supports with modulation of the inflammation-induced interaction between endothelial cells and circulating immune cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.